-
公开(公告)号:WO2022183281A1
公开(公告)日:2022-09-09
申请号:PCT/CA2022/050283
申请日:2022-02-28
IPC分类号: A61K31/14 , A61K31/192 , A61K31/194 , A61K31/195 , A61K31/216 , A61K31/426 , A61K31/661 , A61K31/7068 , A61P21/00 , C07C59/72 , C07C59/255 , C07C69/708 , C07C215/08 , C07C233/73 , C07D277/26 , C07F9/09 , C07H19/10
摘要: Among other things, in general, compositions and methods of treatment for muscular dystrophy and other diseases are disclosed. A method of treatment of a subject is disclosed, in which fatty acid utilization is improved. The method includes administering to the subject in need thereof therapeutically effective amounts of a peroxisome proliferator-activated receptor (Ppar) agonist and of choline, or pharmaceutically acceptable salts or prodrugs thereof. Compositions including a Ppar agonist and choline are also provided.